KPV Peptide For Sale
Principal investigators and laboratory technicians requiring analytical-grade KPV peptide for sale rely on PX1 Research for verified purity, lot-to-lot reproducibility, and comprehensive analytical documentation. Manufactured in GMP-compliant, ISO 17025 accredited facilities in the United States, our tripeptide preparations are strictly formatted for in vitro, ex vivo, and preclinical animal research models.
Quick answer
Principal investigators and laboratory technicians requiring analytical-grade KPV peptide for sale rely on PX1 Research for verified purity, lot-to-lot reproducibility, and comprehensive analytical documentation. Manufactured in GMP-compliant, ISO 17025 accredited facilities in the United States, our tripeptide preparations are strictly formatted for in vitro, ex vivo, and preclinical animal research models.
Key takeaways
- When procurement departments source [KPV peptide for sale](https://px1research.com/peptides/kpv) for laboratory evaluation, they receive a C-terminal tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH).
- [KPV](/research-peptides/kpv) is a shortened structural analog derived from the C-terminal sequence of α-MSH ($ ext{α-MSH}_{11-13}$).
- Preclinical investigations demonstrate that [KPV](/research-peptides/kpv) acts primarily as a downregulator of intracellular proinflammatory signaling.
- A major area of focus for investigators purchasing [KPV](/research-peptides/kpv) peptide for sale centers on gastrointestinal physiology and epithelial barrier maintenance.
Direct Sourcing Summary: KPV (Lys-Pro-Val) Research Reagent
When procurement departments source KPV peptide for sale for laboratory evaluation, they receive a C-terminal tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). Composed of the amino acid sequence Lysine-Proline-Valine, KPV is a specialized anti-inflammatory tripeptide investigated for its capacity to downregulate proinflammatory signaling cascades, suppress nuclear factor kappa B (NF-κB) nuclear translocation, and preserve mucosal structure in preclinical intestinal barrier models. PX1 Research provides USA-manufactured KPV reagents with verified mass spectrometry and HPLC purities exceeding 98%.
To review structural specifications, chemical identifiers, or place an institutional purchase order, explore our KPV 5mg product listing or consult our primary catalog of research peptides. All reagents supplied by PX1 Research are strictly restricted to laboratory research use and are not intended for human or clinical applications.
Molecular Identification and Biochemical Characteristics
KPV is a shortened structural analog derived from the C-terminal sequence of α-MSH ($ ext{α-MSH}_{11-13}$). Despite lacking the full melanocortin receptor-binding domain of its parent 13-amino-acid peptide, the isolated Lys-Pro-Val sequence retains significant bioactivity across non-melanocyte cell populations. Lacking the melanogenic core, KPV does not induce pigmentary pathways or stimulate classical melanocortin-1 receptor (MC1R) transcription to the degree of larger peptide sequences, allowing researchers to isolate its specific intracellular signaling dynamics.
With a molecular weight of approximately 341.41 g/mol, the hydrophilic nature of KPV facilitates rapid cellular uptake via specific peptide transporters such as PepT1 (SLC15A1). In vitro studies indicate that PepT1-mediated transport enables KPV to cross plasma membranes efficiently without requiring specialized lipid delivery vehicles. This pharmacokinetic feature makes KPV an exceptional candidate for assays evaluating intracellular inflammatory cascades and mucosal transport mechanisms.
Preclinical Mechanisms: Inflammatory Pathway Modulation
Preclinical investigations demonstrate that KPV acts primarily as a downregulator of intracellular proinflammatory signaling. The central mechanism identified in published literature involves the inhibition of NF-κB nuclear translocation. NF-κB serves as a master transcription factor responsible for upregulating proinflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). In vitro macrophage and epithelial cell assays reveal that KPV attenuated NF-κB activation following stimulation with lipopolysaccharide (LPS) or tumor necrosis factors.
In addition to NF-κB inhibition, animal studies show that KPV interacts with intracellular importin proteins, preventing the physical transport of active inflammatory protein complexes into the nucleus. This targeted intracellular mechanism allows researchers to examine localized inflammatory control without non-specific receptor activation across non-target tissues. Further details on cytokine suppression pathways can be explored through our peptide research library.
Intestinal Barrier Integrity and Colitis Preclinical Models
A major area of focus for investigators purchasing KPV peptide for sale centers on gastrointestinal physiology and epithelial barrier maintenance. In rodent models of dextran sulfate sodium (DSS)-induced and trinitrobenzene sulfonic acid (TNBS)-induced colitis, oral or parenteral administration of KPV demonstrated significant attenuation of histopathological mucosal damage, reduced myeloperoxidase (MPO) activity, and preserved colon length.
Cellular assays using Caco-2 monolayers indicate that KPV preserves tight junction architecture by upregulating expression of key transmembrane proteins, including Occludin and Zonula Occludens-1 (ZO-1). By mitigating LPS-induced destruction of tight junctions, KPV reduces paracellular permeability across intestinal epithelial sheets. Preclinical data suggest this dual action—direct mucosal cytokine suppression and tight junction preservation—makes KPV a critical reference compound for inflammatory bowel disease (IBD) research models.
Comparative Analysis: KPV vs. Concurrent Cytoprotective Research Compounds
When structuring comparative experimental protocols for mucosal protection or tissue repair, researchers frequently evaluate KPV alongside related signaling molecules. While KPV functions primarily via intracellular PepT1 transport and NF-κB nuclear blocking, other agents act through distinct enzymatic or structural pathways. Evaluating these complementary mechanisms allows multi-target screening in complex cell culture systems.
For example, the pentadecapeptide BPC-157 peptide acts largely via VEGFR2 pathway activation, focal adhesion kinase stimulation, and nitric oxide modulation, making it a primary subject for soft tissue healing studies. Conversely, Larazotide acetate serves as a tight junction regulatory peptide that functions as a competitive antagonist at the zonulin receptor, directly targeting paracellular permeability without primary intracellular cytokine blockade. Comparing KPV peptide against these agents provides a comprehensive toolkit for analyzing distinct phases of epithelial injury, inflammation, and barrier repair.
Laboratory Handling, Solubilization, and Reconstitution Protocols
Proper reconstitution is required to maintain the conformational stability and bioactivity of KPV in cell culture and biochemical assays. Lyophilized KPV powder should be reconstituted using sterile laboratory-grade solvents, such as Bacteriostatic Water, sterile 0.9% Sodium Chloride injection, or sterile Phosphate-Buffered Saline (PBS, pH 7.4), depending on assay parameters.
To reconstitute KPV in a laboratory environment: Allow the glass vial to equilibrate to room temperature (18°C–25°C) before reconstitution to prevent moisture condensation inside the vial. Using a sterile syringe, gently introduce the calculated volume of solvent along the internal glass wall of the vial. Gently swirl or invert the vial until complete dissolution occurs. Avoid vortexing or violent agitation, as shear stress can cause peptide aggregation or denaturation. For institutional labs requiring higher volumes, our wholesale lab accounts offer bulk packaging options designed for high-throughput screening.
Storage, Stability, and Lyophilized Powder Maintenance
Lyophilized KPV peptide should be stored in a sub-zero freezer environment at -20°C to -80°C for long-term stability. Under these conditions, the un-reconstituted peptide maintains chemical integrity and structural stability for up to 24 months. Protect the vial from prolonged exposure to light and atmospheric moisture.
Once reconstituted into aqueous solution, KPV aliquots should be used immediately or stored at -20°C or -80°C to avoid degradation from repeated freeze-thaw cycles. Reconstituted solution stored at 2°C to 8°C should be utilized within 7 to 14 days. Avoid storage in frost-free freezers, as temperature fluctuations during automated defrost cycles compromise peptide bond integrity over time.
Quality Verification: RP-HPLC, Mass Spectrometry, and Endotoxin Limits
Research validity depends entirely on compound purity and batch consistency. Every batch of KPV supplied by PX1 Research undergoes rigorous testing using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to establish chemical purity standards exceeding 98%. RP-HPLC analysis verifies the absence of truncated sequences, residual reagents, or synthetic side products.
Electrospray Ionization Mass Spectrometry (ESI-MS) is simultaneously performed to verify the precise molecular mass ($341.41 ext{ Da}$) and sequence identity of the tripeptide. Furthermore, because KPV is frequently applied to primary cell cultures and immunological models sensitive to bacterial contaminants, every lot undergoes chromogenic LAL endotoxin testing. PX1 Research mandates strict endotoxin limits (< 0.01 EU/mg), preventing confounding inflammatory responses caused by residual endotoxin contamination.
USA Manufacturing Standards and Lot-Level Documentation
PX1 Research manufactures all research compounds within GMP-compliant, ISO 17025 accredited facilities located exclusively in the United States. Sourcing USA-manufactured reagents eliminates vulnerabilities associated with international supply chains, unverified overseas re-packagers, and inconsistent batch quality.
Every KPV shipment includes a Certificate of Analysis (COA) linked to the specific lot number printed on the vial. Institutional buyers can verify raw HPLC chromatograms, mass spectra, and endotoxin assay reports prior to introducing reagents into experimental workflows. This complete traceability guarantees that experimental data remains reproducible across multi-year research projects.
Order Fulfillment and Expedited Facility Logistics
To prevent delays in academic and industrial research schedules, PX1 Research operates dual fulfillment hubs located in California and Arizona. Orders containing KPV peptide for sale placed before 12:00 PM PST Monday through Friday are processed and dispatched the same day.
Reagents are packaged using temp-controlled, insulated shipping materials to protect peptide integrity during transit. Domestic research centers receive expedited courier tracking with full chain-of-custody logging. For emergency reagent replenishment or specialized custom synthesis requests, consult our technical support staff through our master research portal.
Frequently Asked Questions
Where can I source high-purity kpv peptide for sale for laboratory research?
High-purity KPV peptide for sale can be ordered directly from PX1 Research. We provide USA-manufactured KPV tripeptide reagents verified above 98% purity via RP-HPLC and mass spectrometry, accompanied by lot-specific Certificates of Analysis for institutional research.
What is KPV peptide and how is it defined in preclinical literature?
KPV is an anti-inflammatory C-terminal tripeptide derived from alpha-melanocyte-stimulating hormone (α-MSH), consisting of the sequence Lysine-Proline-Valine. It is studied in preclinical research for its ability to block NF-κB activation and reduce proinflammatory cytokine signaling.
What primary research models utilize KPV peptide?
KPV is primarily utilized in cell culture assays and animal models studying inflammatory bowel disease (IBD), mucosal barrier repair, tight junction integrity (ZO-1 and Occludin expression), and localized epithelial inflammation.
How does KPV enter target cells in experimental models?
In vitro studies indicate KPV enters epithelial cells and inflammatory cells via the PepT1 oligopeptide transporter (SLC15A1), allowing rapid intracellular uptake without requiring specialized transfection reagents.
What is the recommended solvent for reconstituting KPV in a lab setting?
Lyophilized KPV can be reconstituted using sterile Bacteriostatic Water, 0.9% sterile saline, or standard Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream assay.
How should reconstituted KPV solutions be stored to prevent degradation?
Reconstituted KPV solutions should be stored at 2°C to 8°C for short-term use (up to 14 days) or aliquoted and stored at -20°C or -80°C for long-term storage to prevent repeated freeze-thaw cycles.
How does PX1 Research verify the purity of KPV peptide?
Every lot of KPV undergoes third-party verification using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity analysis, ESI-Mass Spectrometry for sequence verification, and chromogenic LAL testing for endotoxin levels.
What endotoxin standards are enforced for PX1 Research KPV batches?
PX1 Research enforces strict endotoxin limits of less than 0.01 EU/mg on all KPV lots to ensure that cell culture assays are not confounded by bacterial lipopolysaccharide contamination.
How does KPV compare to BPC-157 in preclinical mucosal research?
While KPV acts predominantly via intracellular PepT1 transport and NF-κB suppression, BPC-157 works via VEGFR2 signaling and focal adhesion pathways. Researchers often use both in comparative protocols studying epithelial defense.
What are the shipping timelines for laboratory KPV orders?
Orders placed before 12:00 PM PST Monday through Friday ship same-day from PX1 Research fulfillment facilities in California and Arizona, arriving via expedited courier with full shipment tracking.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.